Private Equity 8 Hours

Last updated: April 10, 2026, 5:30 AM ET

European Private Equity Activity & Venture Capital

European dealmaking saw distinct movements as GTCR concluded its acquisition of Zentiva, the pharmaceutical firm specializing in generics and over-the-counter medicines, while EQT divested its stake in an unnamed Nordic ferry operator. This activity contrasts with a surge in European venture capital, which minted the highest number of $1 billion-plus startups in four years, signaling continued appetite for high-growth technology despite broader M&A consolidation. Furthermore, the pipeline for future growth is being established, evidenced by the announcement of first-time European VC funds targeting 2026, suggesting capital deployment remains a priority for the coming years.

Sector Focus & Founder Profiles

While large-scale transactions proceed, niche technology creation continues, exemplified by a Swiss founder developing robotic solutions for crêpe production. This focus on specialized automation highlights an area of interest for potential growth equity investment, sitting alongside the broader ecosystem where firms continue to build out their mandates ahead of the next funding cycle detailed in the 2026 VC fund reports.